Drug Trial Radar · NCT06406205
A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
Last checked: Nov 19, 2026Latest source record: May 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
270
Planned (sponsor's estimate)
Start
Dec 25, 2023
Primary completion
Jun 2027
Study completion Jun 2028
Sponsor
- Lead sponsor
- Qilu Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy of QL1074 compared with placebo in achieving renal response after 52 weeks of therapy in subjects with Active Lupus Nephritis.
Conditions
- Lupus Nephritis
Interventions
Voclosporin(QL1074)Drug
QL1074 23.7 mg BlD will be administered as a fixed dose without the use of therapeutic drugmonitoring. The protocol contains provisions for management of dose based on safety concerns, in particular, BP and renal function,can be managed by dose reduction and temporary of QL1074 to interruption.
PlaceboDrug
Placebo softgel capsules, identical to 7.9 mg QL1074, will be provided. The administration plan and dosage management regulations are the same as QL1074.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Complete Renal Remission at Week 52Time frame: Week 52
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China · Recruiting
The People's Hospital of Bozhou
Bozhou, Anhui, China · Recruiting
Anhui Provincial Hospital
Hefei, Anhui, China · Recruiting
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China · Recruiting
Chincse PLA General Hosptial
Beijing, Beijing Municipality, China · Recruiting
Peking University First Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Fujian Medical University Union Hospital
Fuzhou, Fujian, China · Recruiting
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China · Recruiting
Huashan Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.